StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
PACEDIGITK.BO$192.85+5.99%
Fair $192.85+0.0%

PACEDIGITK.BO

PACEDIGITK.BO

Technology / Communication EquipmentBSE

$192.85

+10.90 (+5.99%)

Fairly Valued+0.0%Fair Value $192.85Fund rank 26/100 · Data gapFallback financials|
SA 54/C
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-501.6M · quality 46.0/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 15/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

54/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · PACEDIGITK.BOLocal privado en este navegador · PACEDIGITK.BO
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$41.6B

P/E

16.3x

↓

EV/EBITDA

8.6x

↓

ROE

22.9%

↑

Gross Margin

29.3%

↓

Debt/Equity

0.14

↓
52-Week Range$193
$140$232

TradingView lightweight chart

PACEDIGITK.BO price, volumen y niveles de valoración

Último $192.85Periodo -11.3%
Fair value: $192.85

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+82.2%

FCF CAGR

—

FCF margin

-8.7%

FCF / Net income

-0.79x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $24.39B · net income $2.68B · FCF $-2.12B

2022-FY → 2025-FY

Gross margin

29.3%-2.4% pts

Operating margin

20.6%+15.9% pts

Net margin

11.0%+8.3% pts

FCF margin

-8.7%-22.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$24.39B$24.39B$24.33B$5.03B$4.03B
Net Income$2.68B$2.68B$2.19B$142.9M$109.7M
EBITDA$4.92B$4.92B$3.88B$392.6M$346.3M
EPS12.4012.40———
Gross Margin29.3%29.3%22.8%28.2%31.7%
Operating Margin20.6%20.6%16.8%4.8%4.8%
Net Margin11.0%11.0%9.0%2.8%2.7%
Balance Sheet
Debt/Equity0.140.140.910.600.44
Cash Flow
Free Cash Flow$-2.12B$-2.12B$2.08B$-501.6M$538.6M
Returns
ROE22.9%22.9%40.7%4.5%3.6%
Valuation
P/E16.2916.29———
EV/EBITDA8.628.62———
P/B3.563.56———
Growth & Yield
Revenue Growth0.2%0.2%384.1%24.6%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

11.3%

razonable

EPS terminal req.

$17.11

Spread vs growth

-11.1%

5Y implied EPS CAGR

10.8%

razonable

EPS terminal req.

$20.71

Spread vs growth

-10.6%

10Y implied EPS CAGR

10.4%

razonable

EPS terminal req.

$33.35

Spread vs growth

-10.2%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · available periodreconcilia total -11.3%

Total return

-11.3%

Start / end P/E

n/dx → n/dx

EPS bridge

n/d → 12.40

Residual

-11.3%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-11.3%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.